By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferrer Internacional 

Edifici L'illa
Diagonal, 549 5ª planta
Barcelona    E-08029  Spain
Phone: 34-93-600-3700 Fax: 34-93-490-7078


Medical Device

Company News
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Provide Update On ADASUVE┬« European Commercial Activities 9/19/2014 7:21:03 AM
Ferrer Internacional Licenses Commercialisation Rights For Ozenoxacin In The United States To Medimetriks Pharmaceuticals, Inc. 3/24/2014 11:39:24 AM
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014 10:31:42 AM
Ferrer Internacional To Develop Lorediplon For Insomnia With Ildong Pharmaceuticals And ErgoMed Clinical Research 2/3/2014 9:04:16 AM
Partnership Between AOP Orphan Pharmaceuticals AG and Ferrer Internacional: Joint Marketing of Adasuve® in CEE 10/29/2013 8:45:51 AM
Ferrer Internacional and Medivir AB (MVIRb.F) Enter Agreement for Commercializing a New Treatment for Agitation Associated With Schizophrenia and Bipolar Disease in the Nordics 9/18/2013 10:10:21 AM
Ferrer Internacional Successfully Completes a Phase III Clinical Trial in Adult and Paediatric Patients With Impetigo for Novel Antibacterial Compound Ozenoxacin 6/12/2013 9:11:17 AM
Grupo Ferrer Internacional S.A. Successfully Completes an Absorption, Tolerability and Safety Study in Juveniles as Young as Two Months of Age for Novel Antibacterial Compound Ozenoxacin 10/5/2012 11:00:15 AM
Ferrer Internacional Initiates Phase III Clinical Studies for Novel Antibacterial Compound, Ozenoxacin, in Development as a Topical Treatment for Impetigo and Other Infectious Dermatological Conditions 1/19/2012 10:27:03 AM
APR Applied Pharma Research S.A. and Labtec GmbH Enter Into Exclusive Licensing Agreement With Ferrer Internacional for the Registration and Marketing of Donepezil Oral Dispersible Film in Spain, Portugal and Germany 10/1/2010 8:57:20 AM